Executive Profile

Michael B. Sheffery Ph.D. Founding General Partner, OrbiMed Advisors, L.L.C.

Age	Total Calculated Compensation	This person is connected to 5 Board Members in 5 different organizations across 8 different industries. See Board Relationships
61	--

Background

Dr. Michael B. Sheffery, Mike, Ph.D. is a Founding General Partner at OrbiMed Advisors, L.L.C, Caduceus Private Investments III, L.P., Caduceus Private Investments II, L.P. and Caduceus Private Investments, L.P. Dr. Sheffery joined OrbiMed in 1998 as a Senior Analyst covering the biotechnology industry. Previously, he held the position of a Senior Biotechnology Industry Analyst at Mehta & Isaly from April 1996 to December 1997. From 1984 to 1996, he was the Head of the ... Laboratory of Gene Structure and Expression at Memorial Sloan-Kettering Cancer Center. Dr. Sheffery has been a Director of Teva Biopharmaceuticals USA, Inc. (alternate name CoGenesys Inc.) from June 12, 2006. He serves as a Director of YM BioSciences USA Inc. (alternate name EXIMIAS Pharmaceutical) and Pieris AG. He serves as a Member of Supervisory Board of arGEN-X BV. Dr. Sheffery has been a Director of Neogenesis Pharmaceuticals, Inc. since December 2000. Dr. Sheffery serves as a Director of Affimed Therapeutics AG and served as its Member of Supervisory Board since April 4, 2007. Dr. Sheffery served as a Director at BTHC VI, Inc. He served as a Director of Memory Pharmaceuticals Corp. from May 2000 to September 2004. He has been a Director of Supernus Pharmaceuticals, Inc. from December 2005 to October 29, 2012. He served as an Independent Director of hersys, Inc. from June 2007 to September 2010. He received his Ph.D. in Molecular Biology from Princeton University. Dr. Sheffery holds his B.A. in Biology from Princeton University.

Corporate Headquarters 601 Lexington Avenue at 53rd Street New York, New York 10022-4629 United States Phone: 212-739-6400 Fax: 212-739-6444 Board Members Memberships Director YM BioSciences USA Inc. Director Affimed Therapeutics AG Director Pieris AG Director Teva Biopharmaceuticals USA, Inc. Director BTHC VI, Inc. 2000-2004 Former Director Memory Pharmaceuticals Corp. 2000-N/A Former Director NeoGenesis Pharmaceuticals, Inc. 2005-2012 Former Director and Member of Compensation Committee Supernus Pharmaceuticals, Inc. 2007-2010 Former Independent Director, Member of Nominations Committee and Member of Compensation Committee Athersys, Inc. Education PhD Princeton University BA Princeton University Other Affiliations Athersys, Inc. Memory Pharmaceuticals Corp. YM BioSciences USA Inc. Supernus Pharmaceuticals, Inc. NeoGenesis Pharmaceuticals, Inc. Affimed Therapeutics AG Pieris AG Caduceus Private Investments, L.P. Princeton University Caduceus Private Investments II, L.P. Caduceus Private Investments III, L.P. Teva Biopharmaceuticals USA, Inc. BTHC VI, Inc. arGEN-X BV

Annual Compensation There is no Annual Compensation data available. Stocks Options There is no Stock Options data available. Total Compensation There is no Total Compensation data available.

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.